Navigation Links
FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
Date:7/9/2008

cols were established for each particular type of tumor. The importance of these progressive dose-escalation studies -- which clearly establish safety before escalating to more potent tumoricidal dose levels -- is of primary concern in the development of a new genetic medicine like Rexin-G. Moreover, the establishment of a functional dose-response relationship is of fundamental significance, not only in terms of basic pharmacology, but in establishing the physiological mechanisms-of-action that are of major importance in determining the predictability of a new anti-cancer agent and ultimately in gaining full regulatory approval for Rexin-G in the United States.

Based on the scientific and medicinal merits of Rexin-G, as well as the rarity, seriousness, and lack of effective therapies for metastatic cancers, the granting of a third Orphan Drug Designation by the FDA at this time is both encouraging and confirmatory. Orphan Drug Designation provides important economic incentives and powerful market protections that encourage the development of innovative products in the cancer field. U.S. Orphan Drug Designation provides seven years of market exclusivity for Rexin-G, a reduction in fees and taxes, and additional regulatory support for ongoing R&D initiatives.

About Epeius Biotechnologies

Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its proprietary targeted delivery systems. To learn more about our pipeline of biotechnologies and products that are currently available for licensing and clinical development, please visit our website, http://www.epeiusbiotech.com.

For more information about Rexin-G, on-going clinical trials in the USA and abroad, please contact Dr. Erlinda M. Gordon at egordon@epeiusbiotech.com.

This release was issued on behalf of the
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. US FDA Grants Pediatric Exclusivity for UCBs Keppra(R)
2. Xceed Molecular Grants Gen-Probe License to Xceeds Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics
3. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
4. Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
5. Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
6. Susan G. Komen for the Cure(R) Announces Largest Grants Slate Ever: $100 Million to Speed Delivery of Breast Cancer Discoveries, Cures
7. European Union, State of Brandenburg, Award Grants to Alcat Europe, GmbH
8. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
9. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
10. United States Patent Office Grants CryoCors Request for Patent Interference
11. Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... & Boston, MA (PRWEB) July 28, 2014 ... agreements with two researchers to further develop potential treatments ... malignant brain tumor, in combination with their patented vaccine ... ITI and Duke University, are based on the work ... Division of Neurosurgery at The Preston Robert Tisch Brain ...
(Date:7/28/2014)... It’s a hard truth: Nearly half of recent veterans ... education are failing to obtain a diploma or certificate within ... to an analysis by The Resume Place , a ... of college majors, which leads to underemployment, unemployment or just ... percent of post-9/11 veterans using GI Bill education ...
(Date:7/28/2014)... and COLLEGE STATION, Texas , July 28, ... theatlashotel.com will be a 177-key, 4-star boutique hotel in ... Bryan , Texas.  Photo - ... As the first hotel within ATLAS , ... rooms, a mixture of standard rooms and suites, a sleek restaurant ...
(Date:7/26/2014)... Canada Endoscopy Visualization Systems Market ... the Canada Endoscopy Visualization Systems market. The report ... (in units) and average prices (in US dollars) ... Mid-Range Endoscopy Visualization Systems and Low-End Endoscopy Visualization ... . , The report also provides company shares ...
Breaking Biology Technology:String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 4Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 2Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 3Texas' Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5
... released results of research showing that Vietnam War veterans exposed ... and even greater risks of getting the most aggressive form ... exposed. , The findings, which appear online now and will ... Cancer, are the first to reliably link the ...
... 2008 -- A new interactive web lesson teaches upper-level ... The lesson, developed by William E. Dyer, Montana State ... Journal of Natural Resources and Life Sciences Education ... almost all of the herbicides on the market today ...
... CEO, to Present at UBS Global Life Sciences ... ... a,leading supplier of label-free technology that accelerates the development,of life science and ... led by OrbiMed Advisors, a top global,healthcare investment firm. MPM Capital also ...
Cached Biology Technology:Exposure to Agent Orange linked to prostate cancer in Vietnam veterans 2ForteBio, Inc. Closes $25 Million In Series C Financing 2ForteBio, Inc. Closes $25 Million In Series C Financing 3
(Date:7/28/2014)... found that 73 percent of adult survivors of childhood ... syndrome and related health problems by failing to follow ... issue of the journal Cancer . , Almost ... cancer in the study had metabolic syndrome, an umbrella ... abdominal obesity, elevated triglyceride and other abnormalities that often ...
(Date:7/28/2014)... CITY (July 28, 2014)The Brain & Behavior Research ... Klerman and Freedman Prizes, recognizing exceptional clinical and ... supported by NARSAD Young Investigator Grants. The grants ... in neurobiological and psychosocial research for the prevention, ... that affect one in four people. , Six ...
(Date:7/28/2014)... , July 28, 2014 Research and ... "Biometrics Market in Latin America 2014-2018" report to ... Biometrics measure and analyze biological data. These ... irises, eye retinas, voice patterns, and hand measurements from ... more stored templates. The main purpose of a biometrics ...
Breaking Biology News(10 mins):Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 2The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 3The Brain & Behavior Research Foundation names winners of Klerman and Freedman Prizes 4Biometrics Market in Latin America 2014-2018 2
... 2011) On a continent battered by weather extremes, famine ... the World Agroforestry Centre documents an exciting new trend ... Southern Africa are now significantly boosting yields and incomes ... naturally fertilize their fields. The analysis of two ...
... LA JOLLA, Calif. -- Scripps Health announced today ... using whole genome sequencing to help determine the causes of ... conditions that defy a diagnosis or are unresponsive to standard ... novel approach to accurately diagnosing and treating rare medical cases. ...
... New research has found that hurricane activity is ... for coastal ecosystems and human population. The research ... University of Queensland Global Change Institute and School of ... (Willis Research Fellow) at the University of Exeter,s Exeter ...
Cached Biology News:400,000 farmers in southern Africa using 'fertilizer trees' to improve food security 2400,000 farmers in southern Africa using 'fertilizer trees' to improve food security 3Scripps launches whole genome sequencing study to find root causes of idiopathic diseases 2Scripps launches whole genome sequencing study to find root causes of idiopathic diseases 3Clustered hurricanes reduce impact on ecosystems 2
Peptide-affinity Purified Polyclonal Antibody to Histamine H2 Receptor...
Peptide-affinity Purified Polyclonal Antibody to Retinoic Acid-Induced 3 (RAI3/RAIG1)...
Monoclonal Antibody to GLP Immunogen: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)...
...
Biology Products: